Clinical Application of Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Prostate Cancer.

Inderjeeth, Andrisha-Jade; Topp, Monique; Sanij, Elaine; Castro, Elena; Sandhu, Shahneen

Inderjeeth, Andrisha-Jade; Topp, Monique; Sanij, Elaine; Castro, Elena; Sandhu, Shahneen.

Afiliación

Inderjeeth AJ; Peter MacCallum Cancer Centre, Melbourne, VIC 3065, Australia.
Topp M; Peter MacCallum Cancer Centre, Melbourne, VIC 3065, Australia.
Sanij E; Peter MacCallum Cancer Centre, Melbourne, VIC 3065, Australia.
Castro E; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC 3010, Australia.
Sandhu S; St Vincent's Institute of Medical Research, Fitzroy, VIC 3168, Australia.

Cancers (Basel) ; 14(23)2022 Nov 30.

Article en En | MEDLINE | ID: mdl-36497408

Palabras clave

PARP; PARP inhibitor; niraparib; olaparib; poly(ADP-ribose) polymerase; prostate cancer; rucaparib; talazoparib

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Australia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google